Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
BMC Palliative Care
Published in: BMC Palliative Care 1/2019

Open Access 01-12-2019 | Research article

Expressive writing as a therapeutic intervention for people with advanced disease: a systematic review

Authors: N. Kupeli, G. Chatzitheodorou, N. A. Troop, D. McInnerney, P. Stone, B. Candy

Published in: BMC Palliative Care | Issue 1/2019

Login to get access

Abstract

Background

Expressive writing involves writing about stressful or traumatic experiences. Despite trials in people with advanced disease, no systematic review to date has critiqued the evidence on expressive writing in this population. To synthesise the evidence of the effects of expressive writing on pain, sleep, depression and anxiety in people with advanced disease.

Methods

A systematic review according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines. CINAHL, CENTRAL, PsycINFO and PubMed were searched from January 1986 to March 2018. Other sources included clinical data registers and conference proceedings. Studies were included if they were randomised controlled trials that assessed the impact of an intervention involving expressive writing for adults with advanced disease and/or studies involving linguistic analysis on the expressive writing output. Methodological quality was assessed using the Cochrane risk of bias tool and the Mixed Methods Appraisal Tool. The Grading of Recommendations Assessment, Development and Evaluation tool was used to assess the level of evidence for the outcomes of interest. The protocol of this systematic review has been registered on PROSPERO (CRD42017058193).

Results

Six eligible studies with a total of 288 participants were identified, including four randomised controlled trials. All of the trials were in cancer and recruited predominantly women. None of the interventions were tailored to the population. Studies had methodological shortcomings and evidence was generally of low quality. Combined analysis of the four trials, involving 214 participants in total, showed no clear difference in the effect of expressive writing on sleep, anxiety or depression compared to an active control. Pain was not evaluated in the trials. In contrast, analysis of the four studies that included linguistic analysis alluded to linguistic mechanisms for potential effects.

Conclusion

Although the trial results suggest there is no benefit in expressive writing for people with advanced disease, the current evidence is limited. There is a need for more rigorous trials. It would be of benefit first to undertake exploratory research in trial design including how best to measure impact and in tailoring of the intervention to address the specific needs of people with advanced disease.

Trial registration

The protocol of this systematic review has been registered on PROSPERO, which can be accessed here (registration number: CRD42017058193).
Appendix
Available only for authorised users
Literature
1.
Mitchell AJ, Chan M, Bhatti H, Halton M, Grassi L, Johansen C, et al. Prevalence of depression, anxiety, and adjustment disorder in oncological, haematological, and palliative-care settings: a meta-analysis of 94 interview-based studies. The Lancet Oncology. 2011;12(2):160–74.PubMedCrossRef
2.
Potter J, Hami F, Bryan T, Quigley C. Symptoms in 400 patients referred to palliative care services: prevalence and patterns. Palliat Med. 2003;17(4):310–4.PubMedCrossRef
3.
Ellis LM, Blanke CD, Roach N. Losing “losing the Battle with Cancer”. JAMA Oncol. 2015;1(1):13.PubMedCrossRef
4.
Badr H. Psychosocial interventions for patients with advanced cancer and their families. Am J Lifestyle Med. 2016;10(1):53–63.PubMedCrossRef
5.
von Heymann-Horan AB, Puggaard LB, Nissen KG, Benthien KS, Bidstrup P, Coyne J, et al. Dyadic psychological intervention for patients with cancer and caregivers in home-based specialized palliative care: the Domus model. Palliat Support Care. 2017;16(2):189–97.CrossRef
6.
Spiegel D, Spira J. Supportive-expressive group therapy: a treatment manual of psychosocial intervention for women with recurrent breast cancer: psychosocial treatment laboratory; 1991.
7.
Keall RM, Clayton JM, Butow PN. Therapeutic life review in palliative care: a systematic review of quantitative evaluations. J Pain Symptom Manag. 2015;49(4):747–61.CrossRef
8.
Okuyama T, Akechi T, Mackenzie L, Furukawa TA. Psychotherapy for depression among advanced, incurable cancer patients: a systematic review and meta-analysis. Cancer Treat Rev. 2017;56:16–27.PubMedCrossRef
9.
Beatty L, Kemp E, Butow P, Girgis A, Schofield P, Turner J, et al. A systematic review of psychotherapeutic interventions for women with metastatic breast cancer: context matters. Psycho-oncology. 2018;27(1):34–42.PubMedCrossRef
10.
11.
Atkin N, Vickerstaff V, Candy B. ‘Worried to death’: the assessment and management of anxiety in patients with advanced life-limiting disease, a national survey of palliative medicine physicians. BMC Palliative Care. 2017;16(1):69.PubMedPubMedCentralCrossRef
12.
13.
Pennebaker JW, Beall SK. Confronting a traumatic event: toward an understanding of inhibition and disease. J Abnorm Psychol. 1986;95(3):274–81.PubMedCrossRef
14.
van Middendorp H, Sorbi MJ, van Doornen LJP, Bijlsma JWJ, Geenen R. Feasibility and induced cognitive-emotional change of an emotional disclosure intervention adapted for home application. Patient Educ Couns. 2007;66(2):177–87.PubMedCrossRef
15.
Pennebaker JW. Traumatic experience and psychosomatic disease: exploring the roles of behavioural inhibition, obsession, and confiding. Canadian Psychology/Psychologie canadienne. 1985;26(2):82–95.CrossRef
16.
Pennebaker JW. Writing about emotional experiences as a therapeutic process. Psychol Sci. 1997;8(3):162–6.CrossRef
17.
McGuire KMB, Greenberg MA, Gevirtz R. Autonomic effects of expressive writing in individuals with elevated blood pressure. J Health Psychol. 2005;10(2):197–209.PubMedCrossRef
18.
Petrie KJ, Fontanilla I, Thomas MG, Booth RJ, Pennebaker JW. Effect of written emotional expression on immune function in patients with human immunodeficiency virus infection: a randomized trial. Psychosom Med. 2004;66(2):272–5.PubMedCrossRef
19.
Weinman J, Ebrecht M, Scott S, Walburn J, Dyson M. Enhanced wound healing after emotional disclosure intervention. Br J Health Psychol. 2008;13(1):95–102.PubMedCrossRef
20.
de Moor C, Sterner J, Hall M, Warneke C, Gilani Z, Amato R, et al. A pilot study of the effects of expressive writing on psychological and behavioral adjustment in patients enrolled in a phase II trial of vaccine therapy for metastatic renal cell carcinoma. Health Psychol. 2002;21(6):615–9.PubMedCrossRef
21.
Henry EA, Schlegel RJ, Talley AE, Molix LA, Bettencourt BA. The feasibility and effectiveness of expressive writing for rural and urban breast Cancer survivors. Oncol Nurs Forum. 2010;37(6):749–57.PubMedCrossRef
22.
Rosenberg HJ, Rosenberg SD, Ernstoff MS, Wolford GL, Amdur RJ, Elshamy MR, et al. Expressive disclosure and health outcomes in a prostate cancer population. Int J Psychiatry Med. 2002;32(1):37–53.PubMedCrossRef
23.
Pennebaker JW, Graybeal A. Patterns of natural language use: disclosure, personality, and social integration. Curr Dir Psychol Sci. 2001;10(3):90–3.CrossRef
24.
Merz EL, Fox RS, Malcarne VL. Expressive writing interventions in cancer patients: a systematic review. Health Psychol Rev. 2014;8(3):339–61.PubMedCrossRef
25.
Zachariae R, O'Toole MS. The effect of expressive writing intervention on psychological and physical health outcomes in cancer patients-a systematic review and meta-analysis. Psycho-Oncology. 2015;24(11):1349–59.PubMedPubMedCentralCrossRef
26.
Nyssen OP, Taylor SJ, Wong G, Steed E, Bourke L, Lord J, et al. Does therapeutic writing help people with long-term conditions? Systematic review, realist synthesis and economic considerations. Health Technol Assess. 2016;20(27).CrossRef
27.
Zhou C, Wu Y, An S, Li X. Effect of expressive writing intervention on health outcomes in breast cancer patients: a systematic review and meta-analysis of randomized controlled trials. PLoS One. 2015;10(7):e0131802.PubMedPubMedCentralCrossRef
28.
Sloan DM, Marx BP. Taking pen to hand: evaluating theories underlying the written disclosure paradigm. Clin Psychol Sci Pract. 2004;11(2):121–37.CrossRef
29.
Burton CM, King LA. The health benefits of writing about positive experiences: the role of broadened cognition. Psychol Health. 2009;24(8):867–79.PubMedCrossRef
30.
Low CA, Stanton AL, Danoff-Burg S. Expressive disclosure and benefit finding among breast cancer patients: mechanisms for positive health effects. Health Psychol. 2006;25(2):181–9.PubMedCrossRef
31.
Greenberg MA, Wortman CB, Stone AA. Emotional expression and physical health: revising traumatic memories or fostering self-regulation? J Pers Soc Psychol. 1996;71(3):588.PubMedCrossRef
32.
Lepore SJ, Greenberg MA, Bruno M, Smyth JM. Expressive writing and health: self-regulation of emotion-related experience, physiology, and behavior. In: Lepore SJ, Smyth JM, editors. The writing cure: how expressive writing promotes health and emotional well-being. Washington, DC: American Psychological Association; 2002. p. 99–117.CrossRef
33.
Pennebaker JW, Boyd RL, Jordan K, Blackburn K. The development and psychometric properties of LIWC2015; 2015.
34.
Chung C, Pennebaker JW. The psychological functions of function words. Social Communication. 2007:343–59.
35.
Pennebaker JW, Mayne TJ, Francis ME. Linguistic predictors of adaptive bereavement. J Pers Soc Psychol. 1997;72(4):863–71.PubMedCrossRef
36.
Pennebaker JW, Mehl MR, Niederhoffer KG. Psychological aspects of natural language use: our words. Our Selves Annual Review of Psychology. 2003;54(1):547–77.PubMedCrossRef
37.
Pennebaker JW, Francis ME, Booth RJ. Linguistic inquiry and word count: LIWC 2001. Mahway: Lawrence Erlbaum Associates; 2001. p. 71.
38.
Francis ME, Pennebaker JW. Linguistic inquiry and word count. Technical Report. Dallas: Southern Methodist University; 1993.
39.
Moher D, Liberati A, Tetzlaff J, Altman DG, Group P. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009;6(7):e1000097.PubMedPubMedCentralCrossRef
40.
Niles AN, Haltom KEB, Mulvenna CM, Lieberman MD, Stanton AL. Randomized controlled trial of expressive writing for psychological and physical health: the moderating role of emotional expressivity. Anxiety Stress Coping. 2014;27(1):1–17.PubMedCrossRef
41.
Higgins JPT, Altman DG, Gotzsche PC, Juni P, Moher D, Oxman AD, et al. The Cochrane Collaboration's tool for assessing risk of bias in randomised trials. BMJ. 2011;343:d5928.PubMedPubMedCentralCrossRef
42.
Pluye P, Robert E, Cargo M, Bartlett G, O’cathain A, Griffiths F, et al. Proposal: a mixed methods appraisal tool for systematic mixed studies reviews. Montréal: McGill University; 2011. p. 1–8.
43.
Schünemann HJ, Oxman AD, Higgins JPT, Vist GE, Glasziou P, Akl E, et al. Chapter 11: Completing ‘Summary of findings’ tables and grading the confidence in or quality of the evidence. In: JPT H, Churchill R, Chandler J, Cumpston MS, editors. Cochrane Handbook for Systematic Reviews of Interventions version 520: Cochrane; 2017.
44.
45.
Dijkers M. Introducing GRADE: a systematic approach to rating evidence in systematic reviews and to guideline development. KT Update. 2013;1(5):1–9.
46.
Review Manager (RevMan). [Computer program]. Version 5.3. Copenhagen: The Nordic Cochrane Centre. In: The Nordic Cochrane Centre TCC; 2014.
47.
Deeks JJ, Higgins JP, Altman DG. Analysing data and undertaking meta‐analyses. Cochrane handbook for systematic reviews of interventions version 5.1.0 (updated March 2011). The Cochrane Collaboration; 2011.
48.
Bruera E, Willey J, Cohen M, Palmer JL. Expressive writing in patients receiving palliative care: a feasibility study. J Palliat Med. 2008;11(1):15–9.PubMedCrossRef
49.
Low CA, Stanton AL, Bower JE, Gyllenhammer L. A randomized controlled trial of emotionally expressive writing for women with metastatic breast cancer. Health Psychol. 2010;29(4):460–6.PubMedPubMedCentralCrossRef
50.
Mosher CE, DuHamel KN, Lam J, Dickler M, Li Y, Massie MJ, et al. Randomised trial of expressive writing for distressed metastatic breast cancer patients. Psychol Health. 2012;27(1):88–100.PubMedCrossRef
51.
Imrie S, Troop NA. A pilot study on the effects and feasibility of compassion-focused expressive writing in day hospice patients. Palliative and Supportive Care. 2012;10(02):115–22.PubMedCrossRef
52.
Laccetti M. Expressive writing in women with advanced breast Cancer. Oncol Nurs Forum. 2007;34(5):1019–24.PubMedCrossRef
53.
Radloff LS. The CES-D scale: a self-report depression scale for research in the general population. Appl Psychol Meas. 1977;1(3):385–401.CrossRef
54.
Roth AJ, Kornblith AB, Batel-Copel L, Peabody E, Scher HI, Holland JC. Rapid screening for psychologic distress in men with prostate carcinoma. Cancer. 1998;82(10):1904–8.PubMedCrossRef
55.
Yellen SB, Cella DF, Webster K, Blendowski C, Kaplan E. Measuring fatigue and other anemia-related symptoms with the functional assessment of Cancer therapy (FACT) measurement system. J Pain Symptom Manag. 1997;13(2):63–74.CrossRef
56.
57.
Horowitz M, Wilner N, Alvarez W. Impact of event scale: a measure of subjective stress. Psychosom Med. 1979;41(3):209–18.PubMedCrossRef
58.
McNair D, Lorr M, Droppleman L. Profile of mood states: EdITS manual. San Diego: Educational and Industrial Testing Service; 1981.
59.
Buysse DJ, Reynolds CF, Monk TH, Berman SR, Kupfer DJ. The Pittsburgh sleep quality index: a new instrument for psychiatric practice and research. Psychiatry Res. 1989;28(2):193–213.PubMedCrossRef
60.
Spielberger C. Assessment of anger: the state-trait anger expression scale. Advances in Personality Assessment. 1983;3:112–34.
61.
Brady MJ, Cella DF, Mo F, Bonomi AE, Tulsky DS, Lloyd SR, et al. Reliability and validity of the functional assessment of Cancer therapy-breast quality-of-life instrument. J Clin Oncol. 1997;15(3):974–86.PubMedCrossRef
62.
Smyth JM. Written emotional expression: effect sizes, outcome types, and moderating variables. J Consult Clin Psychol. 1998;66(1):174–84.PubMedCrossRef
63.
Forstmeier W, Wagenmakers E-J, Parker TH. Detecting and avoiding likely false-positive findings - a practical guide. Biol Rev. 2016;92(4):1941–68.PubMedCrossRef
64.
Tausczik YR, Pennebaker JW. The psychological meaning of words: LIWC and computerized text analysis methods. J Lang Soc Psychol. 2010;29(1):24–54.CrossRef
65.
Reinhold M, Bürkner PC, Holling H. Effects of expressive writing on depressive symptoms—a meta-analysis. Clin Psychol Sci Pract. 2018;25:e12224.CrossRef
66.
Willmott L, Harris P, Gellaitry G, Cooper V, Horne R. The effects of expressive writing following first myocardial infarction: a randomized controlled trial. Health Psychol. 2011;30(5):642.PubMedCrossRef
67.
Zakowski SG, Ramati A, Morton C, Johnson P, Flanigan R. Written emotional disclosure buffers the effects of social constraints on distress among cancer patients. Health Psychol. 2004;23(6):555.PubMedCrossRef
68.
Gellaitry G, Peters K, Bloomfield D, Horne R. Narrowing the gap: the effects of an expressive writing intervention on perceptions ofactualandidealemotional support in women who have completed treatment for early stage breast cancer. Psycho-Oncology. 2010;19(1):77–84.PubMedCrossRef
69.
Flemming K. The knowledge base for evidence-based nursing: a role for mixed methods research? Adv Nurs Sci. 2007;30(1):41–51.CrossRef
Metadata
Title
Expressive writing as a therapeutic intervention for people with advanced disease: a systematic review
Authors
N. Kupeli
G. Chatzitheodorou
N. A. Troop
D. McInnerney
P. Stone
B. Candy
Publication date
01-12-2019
Publisher
BioMed Central
Published in
BMC Palliative Care / Issue 1/2019
Electronic ISSN: 1472-684X
DOI
https://doi.org/10.1186/s12904-019-0449-y

Other articles of this Issue 1/2019

BMC Palliative Care 1/2019 Go to the issue

Research article

“I go into crisis when …”: ethics of care and moral dilemmas in palliative care

Research article

Exploring health care providers’ perceptions about home-based palliative care in terminally ill cancer patients

Research article

More comprehensively measuring quality of life in life-threatening illness: the McGill Quality of Life Questionnaire – Expanded

Research article

Examining constipation assessment and management of patients with advanced cancer receiving specialist palliative care: a multi-site retrospective case note review of clinical practice

Research article

Talking about end of life in general palliative care – what’s going on? A qualitative study on end-of-life conversations in an acute care hospital in Denmark

Research article

Completion rate of physician orders for life-sustaining treatment for patients with metastatic or recurrent cancer: a preliminary, cross-sectional study